Columbus Circle Investors’s Regeneron Pharmaceuticals REGN Stock Holding History

Columbus Circle Investors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,600	Closed	-$1.46M	–	180
2020 Q3	$1.46M	Sell	2,600 -12,429	-83%	-$7.54M	0.06%	146
2020 Q2	$9.37M	Buy	15,029 +6,613	+79%	+$3.75M	0.38%	90
2020 Q1	$4.11M	Buy	+8,416	New	+$3.47M	0.23%	121
2015 Q1	–	Sell	-21,398	Closed	-$8.78M	–	323
2014 Q4	$8.78M	Sell	21,398 -29,946	-58%	-$11.8M	0.06%	209
2014 Q3	$18.5M	Buy	51,344 +29,832	+139%	+$10M	0.13%	146
2014 Q2	$6.08M	Sell	21,512 -463,950	-96%	-$138M	0.04%	222
2014 Q1	$146M	Buy	485,462 +74,632	+18%	+$23M	0.97%	33
2013 Q4	$113M	Sell	410,830 -40,687	-9%	-$11.7M	0.77%	42
2013 Q3	$141M	Buy	451,517 +24,299	+6%	+$6.39M	1%	24
2013 Q2	$96.1M	Buy	+427,218	New	+$99.5M	0.77%	41

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Columbus Circle Investors's REGN Position: Q4 2020 in Review

Columbus Circle Investors sold out of Regeneron Pharmaceuticals (REGN) in Q4 2020, closing a stake of 2,600 shares — an estimated $1.46M sold.

Columbus Circle Investors first reported a position in REGN in Q2 2013 and held it in 10 quarters. The position peaked at $146M in Q1 2014. 903 funds tracked by Wall St. Rank hold REGN as of Q4 2020.

Columbus Circle Investors reported no remaining Regeneron Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Columbus Circle Investors sold 2,600 Regeneron Pharmaceuticals shares in Q4 2020, an estimated $1.46M.
Columbus Circle Investors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 10 quarters.
Columbus Circle Investors's Regeneron Pharmaceuticals position peaked at $146M in Q1 2014.
903 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2020.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.